News

The French Ministry for Higher Education and Research extended Comac Medical’s approval as a research and development service provider

We have the pleasure to announce that the French Ministry for Higher Education and Research has granted an extension to the approval of Comac Medical’s Clinical Research Unit (CRU) as a research and development service provider. This allows companies, subject to the French General Tax Code, to take advantage of the research and development tax credit (Le Crédit d’Impôt Recherche (CIR) available in France.

French companies which have outsourced research and development to Comac Medical’s CRU will be able to benefit from the research and development tax credit (Le Crédit d’Impôt Recherche (CIR).

The open-data list of approved organizations is available at: https://lnkd.in/dwkdAcU

 

MEDICAL CENTER COMAC MEDICAL LTD – décision – Agr CIR

Share:
[Sofia, Bulgaria] – Comac Medical is pleased to announce the publication of a new scientific article, co-authored by Professor...
Clinical trial supply management is a critical function in the execution of successful clinical trials. From forecasting and...
Selecting the most appropriate clinical trial design is of utmost importance, and it can be the difference between...